Hannah Jarnagin

Hannah Jarnagin practices at Emory Saint Joseph's Hospital in Atlanta, Georgia, part of Emory University.

Hannah Jarnagin's NPI, 1518615376, was assigned on March 11, 2022. Hannah Jarnagin holds Georgia license 10944.

Hannah Jarnagin's primary practice is Emory Saint Joseph's Hospital, at 5665 Peachtree Dunwoody Road, Atlanta, GA 30342 in Fulton County. The practice phone is (678) 843-7001.

Hannah Jarnagin's primary practice is Emory Saint Joseph's Hospital in Atlanta, Georgia, part of Emory University. The medical group on file is Emory Clinic.

Dmand AI tracks the electronic health record (EHR) system at each site where Hannah Jarnagin practices. Vendor and product names are available with a free account.

Hematology and oncology is Hannah Jarnagin's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Hannah Jarnagin is licensed in Georgia.

CMS data shows 45 Medicare services from Hannah Jarnagin across 2 procedure codes in 2024, for 28 Medicare patients. Medicare paid $3,034 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 28 Medicare patients who saw Hannah Jarnagin in 2024. The largest group is 65 to 74, with 14 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 3.98, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Hannah Jarnagin's median patient age at 68, with 33% women.

In 2024, Hannah Jarnagin wrote 92 Medicare Part D claims for 21 patients. 93% of them were for generic drugs. CMS names the drug for 19 of them, across 1 drug with 11 or more claims each, at $546 in total drug cost. In 2023, CMS named 19 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Hannah Jarnagin for performance year 2024, reported through an alternative payment model (APM).

CMS Open Payments shows 1 general payment to Hannah Jarnagin from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $80.